Rank | Gene Set | Z-score |
---|---|---|
1 | axon ensheathment in central nervous system (GO:0032291) | 9.51381862 |
2 | central nervous system myelination (GO:0022010) | 9.51381862 |
3 | synaptic vesicle maturation (GO:0016188) | 7.37678771 |
4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 7.10414453 |
5 | glutamate secretion (GO:0014047) | 7.03735269 |
6 | fatty acid elongation (GO:0030497) | 6.63401350 |
7 | synaptic vesicle exocytosis (GO:0016079) | 6.24221612 |
8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.84083476 |
9 | * erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.76122597 |
10 | * L-phenylalanine catabolic process (GO:0006559) | 5.76122597 |
11 | cellular potassium ion homeostasis (GO:0030007) | 5.73910544 |
12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.53715421 |
13 | neurotransmitter secretion (GO:0007269) | 5.39557946 |
14 | * erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.28444298 |
15 | * L-phenylalanine metabolic process (GO:0006558) | 5.28444298 |
16 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.28322030 |
17 | regulation of synaptic vesicle transport (GO:1902803) | 5.17023985 |
18 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.06859686 |
19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.04463321 |
20 | sodium ion export (GO:0071436) | 5.01165188 |
21 | ensheathment of neurons (GO:0007272) | 4.85638740 |
22 | axon ensheathment (GO:0008366) | 4.85638740 |
23 | myelination (GO:0042552) | 4.84572866 |
24 | neuronal action potential propagation (GO:0019227) | 4.73191988 |
25 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.54388098 |
26 | neurotransmitter transport (GO:0006836) | 4.49684714 |
27 | potassium ion homeostasis (GO:0055075) | 4.41333274 |
28 | * aromatic amino acid family catabolic process (GO:0009074) | 4.38833273 |
29 | locomotory exploration behavior (GO:0035641) | 4.30120617 |
30 | very long-chain fatty acid metabolic process (GO:0000038) | 4.28218835 |
31 | positive regulation of synapse maturation (GO:0090129) | 4.27904863 |
32 | myelin maintenance (GO:0043217) | 4.19810015 |
33 | potassium ion import (GO:0010107) | 4.19035496 |
34 | regulation of neurotransmitter levels (GO:0001505) | 4.16794816 |
35 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.14306561 |
36 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.14231550 |
37 | amino acid import (GO:0043090) | 4.09539071 |
38 | cholesterol biosynthetic process (GO:0006695) | 4.09371397 |
39 | neuronal ion channel clustering (GO:0045161) | 4.08515055 |
40 | glyoxylate metabolic process (GO:0046487) | 4.03596276 |
41 | bile acid biosynthetic process (GO:0006699) | 4.01532322 |
42 | heme transport (GO:0015886) | 4.01153006 |
43 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.99361898 |
44 | creatine metabolic process (GO:0006600) | 3.98532024 |
45 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.94738011 |
46 | neurotransmitter uptake (GO:0001504) | 3.94672113 |
47 | response to methylmercury (GO:0051597) | 3.93139550 |
48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.91804387 |
49 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.88039255 |
50 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.82989634 |
51 | exploration behavior (GO:0035640) | 3.81183708 |
52 | cerebellar granule cell differentiation (GO:0021707) | 3.80191238 |
53 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.76450374 |
54 | synaptic transmission, glutamatergic (GO:0035249) | 3.75051535 |
55 | alpha-linolenic acid metabolic process (GO:0036109) | 3.73336091 |
56 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.65164037 |
57 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.64104298 |
58 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.63517488 |
59 | sterol biosynthetic process (GO:0016126) | 3.63497340 |
60 | gamma-aminobutyric acid transport (GO:0015812) | 3.63222360 |
61 | regulation of neurotransmitter secretion (GO:0046928) | 3.62235346 |
62 | coenzyme catabolic process (GO:0009109) | 3.62145044 |
63 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.61497494 |
64 | vocalization behavior (GO:0071625) | 3.61154000 |
65 | postsynaptic membrane organization (GO:0001941) | 3.60545021 |
66 | positive regulation of dendritic spine development (GO:0060999) | 3.60385921 |
67 | neuron-neuron synaptic transmission (GO:0007270) | 3.59213238 |
68 | L-serine metabolic process (GO:0006563) | 3.59021145 |
69 | positive regulation of membrane potential (GO:0045838) | 3.58353381 |
70 | tyrosine metabolic process (GO:0006570) | 3.57893541 |
71 | detection of calcium ion (GO:0005513) | 3.57333548 |
72 | cysteine metabolic process (GO:0006534) | 3.56783481 |
73 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.55602880 |
74 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.53956445 |
75 | synaptic vesicle endocytosis (GO:0048488) | 3.51800118 |
76 | regulation of neurotransmitter transport (GO:0051588) | 3.51188073 |
77 | positive regulation of neurotransmitter transport (GO:0051590) | 3.50557956 |
78 | regulation of synaptic plasticity (GO:0048167) | 3.49832941 |
79 | cellular sodium ion homeostasis (GO:0006883) | 3.48326471 |
80 | regulation of synapse structural plasticity (GO:0051823) | 3.46420350 |
81 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.45837233 |
82 | establishment of mitochondrion localization (GO:0051654) | 3.45605232 |
83 | bile acid metabolic process (GO:0008206) | 3.44185954 |
84 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.42994498 |
85 | aspartate family amino acid catabolic process (GO:0009068) | 3.42641409 |
86 | regulation of vesicle fusion (GO:0031338) | 3.42502698 |
87 | protein localization to synapse (GO:0035418) | 3.41861259 |
88 | glycerophospholipid catabolic process (GO:0046475) | 3.40024982 |
89 | acyl-CoA biosynthetic process (GO:0071616) | 3.39179609 |
90 | thioester biosynthetic process (GO:0035384) | 3.39179609 |
91 | iron coordination entity transport (GO:1901678) | 3.38948835 |
92 | dicarboxylic acid catabolic process (GO:0043649) | 3.38777796 |
93 | cofactor catabolic process (GO:0051187) | 3.36644547 |
94 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.35594545 |
95 | acidic amino acid transport (GO:0015800) | 3.34517698 |
96 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.34367341 |
97 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.33262826 |
98 | neuromuscular process controlling posture (GO:0050884) | 3.32667055 |
99 | oligodendrocyte differentiation (GO:0048709) | 3.31197106 |
100 | neuron cell-cell adhesion (GO:0007158) | 3.30620841 |
101 | tryptophan catabolic process (GO:0006569) | 3.30217682 |
102 | indole-containing compound catabolic process (GO:0042436) | 3.30217682 |
103 | indolalkylamine catabolic process (GO:0046218) | 3.30217682 |
104 | amyloid precursor protein metabolic process (GO:0042982) | 3.29892843 |
105 | serine family amino acid biosynthetic process (GO:0009070) | 3.29282483 |
106 | cell communication by electrical coupling (GO:0010644) | 3.28982945 |
107 | regulation of synapse maturation (GO:0090128) | 3.28855446 |
108 | short-chain fatty acid metabolic process (GO:0046459) | 3.27863902 |
109 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.27284924 |
110 | glutamate metabolic process (GO:0006536) | 3.27262913 |
111 | cellular ketone body metabolic process (GO:0046950) | 3.25625461 |
112 | regulation of dopamine metabolic process (GO:0042053) | 3.23154079 |
113 | regulation of catecholamine metabolic process (GO:0042069) | 3.23154079 |
114 | glutamate receptor signaling pathway (GO:0007215) | 3.22246582 |
115 | dendritic spine morphogenesis (GO:0060997) | 3.21785208 |
116 | aldehyde catabolic process (GO:0046185) | 3.18667835 |
117 | neuromuscular process controlling balance (GO:0050885) | 3.18214724 |
118 | auditory behavior (GO:0031223) | 3.16117940 |
119 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.15455705 |
120 | long-term synaptic potentiation (GO:0060291) | 3.14917689 |
121 | thioester metabolic process (GO:0035383) | 3.14791141 |
122 | acyl-CoA metabolic process (GO:0006637) | 3.14791141 |
123 | response to mercury ion (GO:0046689) | 3.13804214 |
124 | tryptophan metabolic process (GO:0006568) | 3.12928382 |
125 | kynurenine metabolic process (GO:0070189) | 3.12153250 |
126 | regulation of lipoprotein metabolic process (GO:0050746) | 3.10897837 |
127 | * aromatic amino acid family metabolic process (GO:0009072) | 3.08675912 |
128 | regulation of postsynaptic membrane potential (GO:0060078) | 3.08398196 |
129 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.08126905 |
130 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.07926885 |
131 | regulation of collateral sprouting (GO:0048670) | 3.06038042 |
132 | negative regulation of neurotransmitter transport (GO:0051589) | 3.05821137 |
133 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.05490107 |
134 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.05105089 |
135 | synaptic vesicle transport (GO:0048489) | 3.04729206 |
136 | establishment of synaptic vesicle localization (GO:0097480) | 3.04729206 |
137 | regulation of dendritic spine development (GO:0060998) | 3.04330996 |
138 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.03511812 |
139 | sulfur amino acid catabolic process (GO:0000098) | 3.02865371 |
140 | * alpha-amino acid catabolic process (GO:1901606) | 3.02298930 |
141 | membrane depolarization during action potential (GO:0086010) | 3.00485819 |
142 | acetyl-CoA metabolic process (GO:0006084) | 3.00121004 |
143 | presynaptic membrane organization (GO:0097090) | 2.98662173 |
144 | amyloid precursor protein catabolic process (GO:0042987) | 2.98373296 |
145 | proline transport (GO:0015824) | 2.98353252 |
146 | cerebellar Purkinje cell layer development (GO:0021680) | 2.97775970 |
147 | L-glutamate transport (GO:0015813) | 2.96830939 |
148 | ethanol oxidation (GO:0006069) | 2.96787436 |
149 | regulation of ARF protein signal transduction (GO:0032012) | 2.94807098 |
150 | high-density lipoprotein particle remodeling (GO:0034375) | 2.94674365 |
151 | glutathione biosynthetic process (GO:0006750) | 2.93082645 |
152 | regulation of synaptic transmission (GO:0050804) | 2.92424245 |
153 | regulation of cholesterol esterification (GO:0010872) | 2.91411854 |
154 | synaptic transmission (GO:0007268) | 2.91138235 |
155 | * cellular amino acid catabolic process (GO:0009063) | 2.90877163 |
156 | transmission of nerve impulse (GO:0019226) | 2.90845455 |
157 | vesicle docking involved in exocytosis (GO:0006904) | 2.89472091 |
158 | substantia nigra development (GO:0021762) | 2.89196155 |
159 | membrane depolarization (GO:0051899) | 2.87544007 |
160 | regulation of fibrinolysis (GO:0051917) | 2.87300400 |
161 | dicarboxylic acid transport (GO:0006835) | 2.86301613 |
162 | regulation of cell communication by electrical coupling (GO:0010649) | 2.85782065 |
163 | ketone body metabolic process (GO:1902224) | 2.84032149 |
164 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.83906263 |
165 | regulation of cholesterol metabolic process (GO:0090181) | 2.83751954 |
166 | signal release (GO:0023061) | 2.83492330 |
167 | plasma lipoprotein particle clearance (GO:0034381) | 2.83290637 |
168 | long-term memory (GO:0007616) | 2.83262363 |
169 | negative regulation of fibrinolysis (GO:0051918) | 2.83110045 |
170 | serine family amino acid metabolic process (GO:0009069) | 2.83051145 |
171 | isoprenoid biosynthetic process (GO:0008299) | 2.82964918 |
172 | cholesterol metabolic process (GO:0008203) | 2.82648890 |
173 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.82525479 |
174 | regulation of triglyceride catabolic process (GO:0010896) | 2.78601662 |
175 | response to auditory stimulus (GO:0010996) | 2.77528096 |
176 | glutathione derivative biosynthetic process (GO:1901687) | 2.76533640 |
177 | glutathione derivative metabolic process (GO:1901685) | 2.76533640 |
178 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.75361263 |
179 | protein carboxylation (GO:0018214) | 2.75361263 |
180 | regulation of exocytosis (GO:0017157) | 2.75357099 |
181 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.75344778 |
182 | import into cell (GO:0098657) | 2.74170862 |
183 | membrane hyperpolarization (GO:0060081) | 2.72653183 |
184 | vesicle docking (GO:0048278) | 2.71949959 |
185 | L-amino acid import (GO:0043092) | 2.70441708 |
186 | negative regulation of protein localization to cell surface (GO:2000009) | 2.69773721 |
187 | opsonization (GO:0008228) | 2.68690028 |
188 | steroid biosynthetic process (GO:0006694) | 2.67515744 |
189 | membrane tubulation (GO:0097320) | 2.67092835 |
190 | drug transmembrane transport (GO:0006855) | 2.66093155 |
191 | sterol metabolic process (GO:0016125) | 2.65188818 |
192 | protein import into peroxisome matrix (GO:0016558) | 2.64502176 |
193 | cholesterol efflux (GO:0033344) | 2.63022740 |
194 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.63014939 |
195 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.63014939 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.19387123 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.34457217 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.57370962 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.49081117 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.36510176 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.06645521 |
7 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.66612917 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.60964460 |
9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.41243360 |
10 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.19234945 |
11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.14661048 |
12 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.14373756 |
13 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.10438146 |
14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.09623438 |
15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.04996096 |
16 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.04386856 |
17 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.03291475 |
18 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.94678097 |
19 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.93473916 |
20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.93128169 |
21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.91375619 |
22 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.90427675 |
23 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.75942156 |
24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.61350646 |
25 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.58308014 |
26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.55214308 |
27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.53762919 |
28 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.53076526 |
29 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.52766821 |
30 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.45217306 |
31 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.41151532 |
32 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.38770247 |
33 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.37763735 |
34 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36580242 |
35 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.32713452 |
36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.31699108 |
37 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29784883 |
38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.29214530 |
39 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.26765486 |
40 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.26765486 |
41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.24075745 |
42 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.21319052 |
43 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.21023301 |
44 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20777203 |
45 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.19742558 |
46 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.18972765 |
47 | VDR_22108803_ChIP-Seq_LS180_Human | 1.18252641 |
48 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.17246261 |
49 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.17246261 |
50 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.17159128 |
51 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.16342029 |
52 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.15700635 |
53 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.15545077 |
54 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.15141726 |
55 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.13787475 |
56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13648498 |
57 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.13635516 |
58 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.12760420 |
59 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.12587868 |
60 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.12425634 |
61 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12239601 |
62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11957902 |
63 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.11485887 |
64 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.11090326 |
65 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08914979 |
66 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.08685790 |
67 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.08278693 |
68 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08102562 |
69 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.07715301 |
70 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07107920 |
71 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.06116362 |
72 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.04268869 |
73 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.03984947 |
74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.03819408 |
75 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03201337 |
76 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.02680542 |
77 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.02126214 |
78 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00745109 |
79 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.00711912 |
80 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.98806430 |
81 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.98122137 |
82 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98072740 |
83 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.96563886 |
84 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96413406 |
85 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.95622972 |
86 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95041042 |
87 | * AR_19668381_ChIP-Seq_PC3_Human | 0.94517066 |
88 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.94309080 |
89 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.93998331 |
90 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.93869942 |
91 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.92556740 |
92 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.92476485 |
93 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92437168 |
94 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91230235 |
95 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91045585 |
96 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91045585 |
97 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90972262 |
98 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90590052 |
99 | NCOR_22424771_ChIP-Seq_293T_Human | 0.89832471 |
100 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.89637369 |
101 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.89595258 |
102 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88059850 |
103 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.87612128 |
104 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.87345224 |
105 | CBP_21632823_ChIP-Seq_H3396_Human | 0.86996475 |
106 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.86844104 |
107 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.84589331 |
108 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83748464 |
109 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81441973 |
110 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.81418693 |
111 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.80800959 |
112 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80257470 |
113 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80243079 |
114 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80152812 |
115 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79983908 |
116 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.79848419 |
117 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.78408805 |
118 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.78351682 |
119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78282549 |
120 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.77863044 |
121 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.77104381 |
122 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.76990296 |
123 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.76053738 |
124 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.75930345 |
125 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.75926587 |
126 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75819308 |
127 | P300_19829295_ChIP-Seq_ESCs_Human | 0.75473440 |
128 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.75116534 |
129 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.74583685 |
130 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.73292129 |
131 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.73160223 |
132 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.73094314 |
133 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.73021220 |
134 | TCF4_23295773_ChIP-Seq_U87_Human | 0.72996744 |
135 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.72608648 |
136 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.72328274 |
137 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.71964348 |
138 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.71853704 |
139 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.71576816 |
140 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.71407733 |
141 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.71272902 |
142 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.71002411 |
143 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.70995148 |
144 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.70272159 |
145 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70243983 |
146 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.70024093 |
147 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.69799123 |
148 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69168639 |
149 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.69071359 |
150 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.68589822 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.14351895 |
2 | MP0005360_urolithiasis | 4.65313502 |
3 | MP0000920_abnormal_myelination | 4.15031498 |
4 | MP0003806_abnormal_nucleotide_metabolis | 4.11872911 |
5 | MP0005085_abnormal_gallbladder_physiolo | 3.74054013 |
6 | MP0005365_abnormal_bile_salt | 3.49369642 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.34447390 |
8 | MP0003195_calcinosis | 3.16741878 |
9 | MP0003690_abnormal_glial_cell | 2.72868011 |
10 | MP0009840_abnormal_foam_cell | 2.65771862 |
11 | MP0003329_amyloid_beta_deposits | 2.56714887 |
12 | MP0001968_abnormal_touch/_nociception | 2.48068992 |
13 | MP0004043_abnormal_pH_regulation | 2.39025780 |
14 | MP0003880_abnormal_central_pattern | 2.36916123 |
15 | MP0004270_analgesia | 2.26946266 |
16 | MP0005332_abnormal_amino_acid | 2.25428575 |
17 | MP0001501_abnormal_sleep_pattern | 2.22442074 |
18 | MP0003879_abnormal_hair_cell | 2.19905880 |
19 | MP0009780_abnormal_chondrocyte_physiolo | 2.15848471 |
20 | MP0005083_abnormal_biliary_tract | 2.15432031 |
21 | MP0004142_abnormal_muscle_tone | 2.09892152 |
22 | MP0001529_abnormal_vocalization | 2.08307688 |
23 | MP0004885_abnormal_endolymph | 1.99153767 |
24 | MP0005451_abnormal_body_composition | 1.96235653 |
25 | MP0003950_abnormal_plasma_membrane | 1.94422699 |
26 | MP0002272_abnormal_nervous_system | 1.87476022 |
27 | MP0002735_abnormal_chemical_nociception | 1.84094297 |
28 | MP0005646_abnormal_pituitary_gland | 1.83411820 |
29 | MP0001666_abnormal_nutrient_absorption | 1.80400825 |
30 | MP0002736_abnormal_nociception_after | 1.78204316 |
31 | MP0003252_abnormal_bile_duct | 1.75974671 |
32 | MP0000604_amyloidosis | 1.75732863 |
33 | MP0010329_abnormal_lipoprotein_level | 1.74508067 |
34 | MP0003787_abnormal_imprinting | 1.73656875 |
35 | MP0001984_abnormal_olfaction | 1.71863683 |
36 | MP0001905_abnormal_dopamine_level | 1.71855488 |
37 | MP0003122_maternal_imprinting | 1.69346609 |
38 | MP0002118_abnormal_lipid_homeostasis | 1.68026645 |
39 | MP0001486_abnormal_startle_reflex | 1.66333870 |
40 | MP0003634_abnormal_glial_cell | 1.64437433 |
41 | MP0002557_abnormal_social/conspecific_i | 1.62836246 |
42 | MP0002064_seizures | 1.60448012 |
43 | MP0004811_abnormal_neuron_physiology | 1.59907856 |
44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53407523 |
45 | MP0003123_paternal_imprinting | 1.49003465 |
46 | MP0002229_neurodegeneration | 1.47885842 |
47 | MP0001485_abnormal_pinna_reflex | 1.47272040 |
48 | MP0002909_abnormal_adrenal_gland | 1.44910222 |
49 | MP0004742_abnormal_vestibular_system | 1.44292041 |
50 | MP0006276_abnormal_autonomic_nervous | 1.34041960 |
51 | MP0008260_abnormal_autophagy | 1.33525987 |
52 | MP0003656_abnormal_erythrocyte_physiolo | 1.32632736 |
53 | MP0002822_catalepsy | 1.29400596 |
54 | MP0003632_abnormal_nervous_system | 1.24526351 |
55 | MP0004381_abnormal_hair_follicle | 1.24038912 |
56 | MP0005410_abnormal_fertilization | 1.22745176 |
57 | MP0005058_abnormal_lysosome_morphology | 1.22658406 |
58 | MP0009745_abnormal_behavioral_response | 1.21968314 |
59 | MP0003633_abnormal_nervous_system | 1.20297636 |
60 | MP0003631_nervous_system_phenotype | 1.17661955 |
61 | MP0004859_abnormal_synaptic_plasticity | 1.16111333 |
62 | MP0003191_abnormal_cellular_cholesterol | 1.15979618 |
63 | MP0003136_yellow_coat_color | 1.12554241 |
64 | MP0005171_absent_coat_pigmentation | 1.12430336 |
65 | MP0001177_atelectasis | 1.12185235 |
66 | MP0003186_abnormal_redox_activity | 1.11015000 |
67 | MP0005423_abnormal_somatic_nervous | 1.10836171 |
68 | MP0000462_abnormal_digestive_system | 1.08702958 |
69 | MP0001661_extended_life_span | 1.08504235 |
70 | MP0005408_hypopigmentation | 1.08274615 |
71 | MP0003635_abnormal_synaptic_transmissio | 1.08161614 |
72 | MP0003868_abnormal_feces_composition | 1.07958550 |
73 | MP0006036_abnormal_mitochondrial_physio | 1.03168046 |
74 | MP0000778_abnormal_nervous_system | 1.02550145 |
75 | MP0002734_abnormal_mechanical_nocicepti | 1.00940951 |
76 | MP0004147_increased_porphyrin_level | 1.00830870 |
77 | MP0008877_abnormal_DNA_methylation | 0.99399561 |
78 | MP0002638_abnormal_pupillary_reflex | 0.98051848 |
79 | MP0004019_abnormal_vitamin_homeostasis | 0.97672951 |
80 | MP0005167_abnormal_blood-brain_barrier | 0.96294711 |
81 | MP0000747_muscle_weakness | 0.95321999 |
82 | MP0000955_abnormal_spinal_cord | 0.95033967 |
83 | MP0002184_abnormal_innervation | 0.94115057 |
84 | MP0001764_abnormal_homeostasis | 0.93531950 |
85 | MP0008872_abnormal_physiological_respon | 0.92400637 |
86 | MP0009046_muscle_twitch | 0.91779398 |
87 | MP0010386_abnormal_urinary_bladder | 0.91048905 |
88 | MP0000609_abnormal_liver_physiology | 0.90800558 |
89 | MP0005551_abnormal_eye_electrophysiolog | 0.90139472 |
90 | MP0002152_abnormal_brain_morphology | 0.89356443 |
91 | MP0002066_abnormal_motor_capabilities/c | 0.88987625 |
92 | MP0000639_abnormal_adrenal_gland | 0.88868167 |
93 | MP0009643_abnormal_urine_homeostasis | 0.84751613 |
94 | MP0002572_abnormal_emotion/affect_behav | 0.82519359 |
95 | MP0001970_abnormal_pain_threshold | 0.80287065 |
96 | MP0002069_abnormal_eating/drinking_beha | 0.79474589 |
97 | MP0002876_abnormal_thyroid_physiology | 0.78758185 |
98 | MP0009765_abnormal_xenobiotic_induced | 0.77658195 |
99 | MP0002882_abnormal_neuron_morphology | 0.76284896 |
100 | MP0005409_darkened_coat_color | 0.76041395 |
101 | MP0002090_abnormal_vision | 0.76014907 |
102 | MP0005319_abnormal_enzyme/_coenzyme | 0.75840592 |
103 | MP0000566_synostosis | 0.75833632 |
104 | MP0001440_abnormal_grooming_behavior | 0.75762277 |
105 | MP0006082_CNS_inflammation | 0.74521060 |
106 | MP0002063_abnormal_learning/memory/cond | 0.73704017 |
107 | MP0001986_abnormal_taste_sensitivity | 0.73400152 |
108 | MP0005636_abnormal_mineral_homeostasis | 0.73344760 |
109 | MP0003172_abnormal_lysosome_physiology | 0.73189713 |
110 | MP0010678_abnormal_skin_adnexa | 0.72570702 |
111 | MP0003121_genomic_imprinting | 0.70515305 |
112 | MP0005535_abnormal_body_temperature | 0.70482979 |
113 | MP0005386_behavior/neurological_phenoty | 0.70463984 |
114 | MP0004924_abnormal_behavior | 0.70463984 |
115 | MP0002733_abnormal_thermal_nociception | 0.68960864 |
116 | MP0001963_abnormal_hearing_physiology | 0.68045029 |
117 | MP0002067_abnormal_sensory_capabilities | 0.67807943 |
118 | MP0008569_lethality_at_weaning | 0.66972272 |
119 | MP0003137_abnormal_impulse_conducting | 0.65299425 |
120 | MP0008874_decreased_physiological_sensi | 0.64261750 |
121 | MP0000579_abnormal_nail_morphology | 0.61325221 |
122 | MP0002138_abnormal_hepatobiliary_system | 0.60274916 |
123 | MP0005645_abnormal_hypothalamus_physiol | 0.59786117 |
124 | MP0002752_abnormal_somatic_nervous | 0.59457845 |
125 | MP0004215_abnormal_myocardial_fiber | 0.59128620 |
126 | MP0000647_abnormal_sebaceous_gland | 0.58568388 |
127 | MP0001502_abnormal_circadian_rhythm | 0.58128005 |
128 | MP0003075_altered_response_to | 0.57876759 |
129 | MP0005195_abnormal_posterior_eye | 0.57037249 |
130 | MP0001346_abnormal_lacrimal_gland | 0.56329817 |
131 | MP0009697_abnormal_copulation | 0.56236702 |
132 | MP0000631_abnormal_neuroendocrine_gland | 0.52850910 |
133 | MP0003283_abnormal_digestive_organ | 0.51976496 |
134 | MP0005379_endocrine/exocrine_gland_phen | 0.51697189 |
135 | MP0001188_hyperpigmentation | 0.51611796 |
136 | MP0003956_abnormal_body_size | 0.50926220 |
137 | MP0006072_abnormal_retinal_apoptosis | 0.50456548 |
138 | MP0005253_abnormal_eye_physiology | 0.50454161 |
139 | MP0004145_abnormal_muscle_electrophysio | 0.49996582 |
140 | MP0002078_abnormal_glucose_homeostasis | 0.48410112 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.28155071 |
2 | Focal seizures (HP:0007359) | 5.09504417 |
3 | Neurofibrillary tangles (HP:0002185) | 5.06681516 |
4 | * Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.85715459 |
5 | Action tremor (HP:0002345) | 4.76782058 |
6 | Intrahepatic cholestasis (HP:0001406) | 4.70335247 |
7 | Limb dystonia (HP:0002451) | 4.62059541 |
8 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.53351190 |
9 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.53351190 |
10 | Febrile seizures (HP:0002373) | 4.50280891 |
11 | Abnormality of binocular vision (HP:0011514) | 4.41214280 |
12 | Diplopia (HP:0000651) | 4.41214280 |
13 | Epileptic encephalopathy (HP:0200134) | 4.41114254 |
14 | Atonic seizures (HP:0010819) | 4.28625240 |
15 | Generalized tonic-clonic seizures (HP:0002069) | 3.86392554 |
16 | Abnormal eating behavior (HP:0100738) | 3.80553653 |
17 | Deep venous thrombosis (HP:0002625) | 3.76329059 |
18 | Hyperlipoproteinemia (HP:0010980) | 3.69911406 |
19 | Xanthomatosis (HP:0000991) | 3.67225535 |
20 | Cerebral inclusion bodies (HP:0100314) | 3.61543700 |
21 | Prolonged partial thromboplastin time (HP:0003645) | 3.56669183 |
22 | Torticollis (HP:0000473) | 3.52076856 |
23 | Abnormality of the corticospinal tract (HP:0002492) | 3.50969971 |
24 | Cerebral hypomyelination (HP:0006808) | 3.39598978 |
25 | Visual hallucinations (HP:0002367) | 3.38797848 |
26 | Absence seizures (HP:0002121) | 3.36446926 |
27 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.27722240 |
28 | Dialeptic seizures (HP:0011146) | 3.26483070 |
29 | Focal dystonia (HP:0004373) | 3.23381666 |
30 | Tetraplegia (HP:0002445) | 3.21306263 |
31 | Postural instability (HP:0002172) | 3.18893105 |
32 | Mutism (HP:0002300) | 3.17986617 |
33 | Hypobetalipoproteinemia (HP:0003563) | 3.17520396 |
34 | Abnormality of methionine metabolism (HP:0010901) | 3.17509886 |
35 | Sensory axonal neuropathy (HP:0003390) | 3.13866742 |
36 | Peripheral hypomyelination (HP:0007182) | 3.11889934 |
37 | Hemiparesis (HP:0001269) | 3.10900191 |
38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.02774658 |
39 | Anxiety (HP:0000739) | 3.00148496 |
40 | Craniofacial dystonia (HP:0012179) | 2.99690474 |
41 | Parakeratosis (HP:0001036) | 2.95052221 |
42 | Progressive cerebellar ataxia (HP:0002073) | 2.94040850 |
43 | Spastic paraparesis (HP:0002313) | 2.93725839 |
44 | Leukodystrophy (HP:0002415) | 2.91643031 |
45 | Status epilepticus (HP:0002133) | 2.91307024 |
46 | Onion bulb formation (HP:0003383) | 2.91048504 |
47 | Delusions (HP:0000746) | 2.90689160 |
48 | Rigidity (HP:0002063) | 2.89957749 |
49 | Hyperammonemia (HP:0001987) | 2.88388218 |
50 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.87759487 |
51 | Abnormality of glycine metabolism (HP:0010895) | 2.87759487 |
52 | Bradykinesia (HP:0002067) | 2.84213622 |
53 | Spastic gait (HP:0002064) | 2.82733824 |
54 | Supranuclear gaze palsy (HP:0000605) | 2.79383832 |
55 | Increased serum pyruvate (HP:0003542) | 2.78970902 |
56 | Abnormality of glycolysis (HP:0004366) | 2.78970902 |
57 | Akinesia (HP:0002304) | 2.78428834 |
58 | Ketosis (HP:0001946) | 2.75179823 |
59 | Epileptiform EEG discharges (HP:0011182) | 2.74631097 |
60 | Truncal ataxia (HP:0002078) | 2.73254438 |
61 | Papilledema (HP:0001085) | 2.72801609 |
62 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.71180220 |
63 | Axonal loss (HP:0003447) | 2.71163799 |
64 | Fat malabsorption (HP:0002630) | 2.70583904 |
65 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.70496912 |
66 | Myokymia (HP:0002411) | 2.67858831 |
67 | Cerebral hemorrhage (HP:0001342) | 2.67050872 |
68 | Urinary urgency (HP:0000012) | 2.66731057 |
69 | Depression (HP:0000716) | 2.65914433 |
70 | Intention tremor (HP:0002080) | 2.63997994 |
71 | Abnormal auditory evoked potentials (HP:0006958) | 2.63202631 |
72 | Neuronal loss in central nervous system (HP:0002529) | 2.59312096 |
73 | Hyperglycinemia (HP:0002154) | 2.59197272 |
74 | Hemiplegia (HP:0002301) | 2.56778328 |
75 | Polyphagia (HP:0002591) | 2.56321230 |
76 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.53546243 |
77 | Lower limb muscle weakness (HP:0007340) | 2.52238622 |
78 | * Choreoathetosis (HP:0001266) | 2.49420297 |
79 | EEG with generalized epileptiform discharges (HP:0011198) | 2.49085223 |
80 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.47843696 |
81 | Clonus (HP:0002169) | 2.46361626 |
82 | Dysmetria (HP:0001310) | 2.45821009 |
83 | Scanning speech (HP:0002168) | 2.44929493 |
84 | Abnormal gallbladder physiology (HP:0012438) | 2.43594186 |
85 | Cholecystitis (HP:0001082) | 2.43594186 |
86 | Annular pancreas (HP:0001734) | 2.43418785 |
87 | Poor eye contact (HP:0000817) | 2.41015118 |
88 | Hypophosphatemic rickets (HP:0004912) | 2.40580804 |
89 | Paraparesis (HP:0002385) | 2.38540527 |
90 | CNS hypomyelination (HP:0003429) | 2.38399135 |
91 | Steatorrhea (HP:0002570) | 2.37834753 |
92 | Conjugated hyperbilirubinemia (HP:0002908) | 2.35586989 |
93 | Complement deficiency (HP:0004431) | 2.35553472 |
94 | Pheochromocytoma (HP:0002666) | 2.35388892 |
95 | Cerebral edema (HP:0002181) | 2.34662044 |
96 | Amblyopia (HP:0000646) | 2.34406913 |
97 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.33077195 |
98 | Hypsarrhythmia (HP:0002521) | 2.32741779 |
99 | Epidermoid cyst (HP:0200040) | 2.31540319 |
100 | Ankle clonus (HP:0011448) | 2.31143938 |
101 | Acute encephalopathy (HP:0006846) | 2.30859774 |
102 | Dysdiadochokinesis (HP:0002075) | 2.29732157 |
103 | Spastic tetraparesis (HP:0001285) | 2.28930069 |
104 | Delayed CNS myelination (HP:0002188) | 2.27511187 |
105 | Slow saccadic eye movements (HP:0000514) | 2.27268235 |
106 | Amyloidosis (HP:0011034) | 2.27100984 |
107 | Hypoglycemic coma (HP:0001325) | 2.26792655 |
108 | Increased circulating renin level (HP:0000848) | 2.25034971 |
109 | 3-Methylglutaconic aciduria (HP:0003535) | 2.24568973 |
110 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.23456633 |
111 | Retinal dysplasia (HP:0007973) | 2.23261978 |
112 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.22667608 |
113 | Apathy (HP:0000741) | 2.21056881 |
114 | Termporal pattern (HP:0011008) | 2.18222104 |
115 | Insidious onset (HP:0003587) | 2.18222104 |
116 | Alacrima (HP:0000522) | 2.17688237 |
117 | Hypokalemic alkalosis (HP:0001949) | 2.15863706 |
118 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.14979040 |
119 | Alkalosis (HP:0001948) | 2.14024459 |
120 | Sleep apnea (HP:0010535) | 2.12881780 |
121 | Diminished movement (HP:0002374) | 2.12779676 |
122 | Diminished motivation (HP:0000745) | 2.10429157 |
123 | Methylmalonic acidemia (HP:0002912) | 2.09828368 |
124 | Joint hemorrhage (HP:0005261) | 2.09709293 |
125 | Postural tremor (HP:0002174) | 2.08249545 |
126 | Vascular calcification (HP:0004934) | 2.06398841 |
127 | Muscular hypotonia of the trunk (HP:0008936) | 2.05747296 |
128 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.05622389 |
129 | Abnormality of serum amino acid levels (HP:0003112) | 2.04974330 |
130 | Metabolic alkalosis (HP:0200114) | 2.04565606 |
131 | Renal Fanconi syndrome (HP:0001994) | 2.04340722 |
132 | Hypolipoproteinemia (HP:0010981) | 2.04269566 |
133 | Neuroendocrine neoplasm (HP:0100634) | 2.04160819 |
134 | Lethargy (HP:0001254) | 2.03419374 |
135 | Opisthotonus (HP:0002179) | 2.02265810 |
136 | Abnormal gallbladder morphology (HP:0012437) | 2.00106290 |
137 | Hypokinesia (HP:0002375) | 1.99949299 |
138 | Rapidly progressive (HP:0003678) | 1.98046271 |
139 | Hyperglycinuria (HP:0003108) | 1.98025760 |
140 | Obstructive sleep apnea (HP:0002870) | 1.96241670 |
141 | Dicarboxylic aciduria (HP:0003215) | 1.96150922 |
142 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.96150922 |
143 | Peripheral demyelination (HP:0011096) | 1.95740025 |
144 | Abnormality of the common coagulation pathway (HP:0010990) | 1.95589600 |
145 | Bundle branch block (HP:0011710) | 1.95188907 |
146 | Stridor (HP:0010307) | 1.93123975 |
147 | Abnormal social behavior (HP:0012433) | 1.92853537 |
148 | Impaired social interactions (HP:0000735) | 1.92853537 |
149 | Impaired vibratory sensation (HP:0002495) | 1.91773172 |
150 | Hyperbilirubinemia (HP:0002904) | 1.90850215 |
151 | Delayed myelination (HP:0012448) | 1.90764444 |
152 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.90170858 |
153 | Abnormality of the lower motor neuron (HP:0002366) | 1.90061302 |
154 | Ketoacidosis (HP:0001993) | 1.89582312 |
155 | Confusion (HP:0001289) | 1.89255061 |
156 | Split foot (HP:0001839) | 1.89217784 |
157 | Metabolic acidosis (HP:0001942) | 1.89182892 |
158 | Retinal atrophy (HP:0001105) | 1.88774330 |
159 | Hepatosplenomegaly (HP:0001433) | 1.88330210 |
160 | Rickets (HP:0002748) | 1.88176519 |
161 | Poor speech (HP:0002465) | 1.88139908 |
162 | Hypoglycemic seizures (HP:0002173) | 1.87497085 |
163 | Fetal akinesia sequence (HP:0001989) | 1.81168807 |
164 | Abnormality of the periventricular white matter (HP:0002518) | 1.81157592 |
165 | Abnormality of saccadic eye movements (HP:0000570) | 1.80402489 |
166 | Incomplete penetrance (HP:0003829) | 1.78103020 |
167 | Dysarthria (HP:0001260) | 1.77218626 |
168 | Ventricular fibrillation (HP:0001663) | 1.74981656 |
169 | Dementia (HP:0000726) | 1.74836587 |
170 | Insomnia (HP:0100785) | 1.73899937 |
171 | Impaired smooth pursuit (HP:0007772) | 1.73412208 |
172 | Psychosis (HP:0000709) | 1.72061943 |
173 | Poor suck (HP:0002033) | 1.71243465 |
174 | Heart block (HP:0012722) | 1.71212995 |
175 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.69678917 |
176 | Gait ataxia (HP:0002066) | 1.68321156 |
177 | Spastic tetraplegia (HP:0002510) | 1.68208215 |
178 | Gaze-evoked nystagmus (HP:0000640) | 1.67221014 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 5.96970550 |
2 | OXSR1 | 4.69264761 |
3 | NTRK3 | 3.88018488 |
4 | PKN1 | 2.91909036 |
5 | BCKDK | 2.71892545 |
6 | WNK4 | 2.71888241 |
7 | EPHB1 | 2.64319101 |
8 | MAP3K9 | 2.63879150 |
9 | CDK19 | 2.58317219 |
10 | FGFR2 | 2.57099563 |
11 | BCR | 2.51097753 |
12 | MET | 2.47679262 |
13 | PBK | 2.39744983 |
14 | MAPKAPK5 | 2.38369992 |
15 | TESK2 | 2.25493807 |
16 | CSNK1G3 | 2.23651248 |
17 | MINK1 | 2.12727532 |
18 | CAMKK1 | 2.12087655 |
19 | CSNK1A1L | 2.04186900 |
20 | PLK2 | 2.01665385 |
21 | LIMK1 | 1.99589627 |
22 | UHMK1 | 1.99045357 |
23 | NTRK1 | 1.96177897 |
24 | GRK5 | 1.91969802 |
25 | CSNK1G1 | 1.73908518 |
26 | WNK1 | 1.70380232 |
27 | CSNK1G2 | 1.70323891 |
28 | DAPK1 | 1.56887694 |
29 | SGK494 | 1.51557435 |
30 | SGK223 | 1.51557435 |
31 | MAPK15 | 1.48269044 |
32 | CAMK1 | 1.39382329 |
33 | NEK6 | 1.31015839 |
34 | MAPK13 | 1.28671048 |
35 | TESK1 | 1.27074279 |
36 | ROCK2 | 1.22542994 |
37 | EPHA4 | 1.19710544 |
38 | LATS2 | 1.19032815 |
39 | CAMKK2 | 1.15795173 |
40 | ARAF | 1.15396438 |
41 | * CAMK2B | 1.14509188 |
42 | PINK1 | 1.13630657 |
43 | INSRR | 1.12588365 |
44 | RIPK1 | 1.10636467 |
45 | PAK6 | 1.08601062 |
46 | TNIK | 1.07576478 |
47 | ERBB4 | 1.05383681 |
48 | DYRK2 | 1.00692833 |
49 | MAP3K12 | 1.00372263 |
50 | ICK | 0.99777719 |
51 | * CAMK2G | 0.96830156 |
52 | DYRK1A | 0.95110882 |
53 | PHKG2 | 0.92537687 |
54 | PHKG1 | 0.92537687 |
55 | MAP3K11 | 0.91633576 |
56 | ALK | 0.91567508 |
57 | KSR2 | 0.91228354 |
58 | * CAMK2D | 0.89879411 |
59 | FGR | 0.88572922 |
60 | PNCK | 0.86408274 |
61 | PRPF4B | 0.86129382 |
62 | PRKD1 | 0.84806374 |
63 | PDPK1 | 0.83273628 |
64 | PRKCQ | 0.81003195 |
65 | CDK5 | 0.80032413 |
66 | PAK3 | 0.79373202 |
67 | CDK14 | 0.78836693 |
68 | CLK1 | 0.76423645 |
69 | BRSK1 | 0.76104816 |
70 | DAPK2 | 0.73845899 |
71 | SGK1 | 0.73416278 |
72 | MARK1 | 0.72693956 |
73 | STK38 | 0.72679177 |
74 | MAPK10 | 0.70665986 |
75 | MARK2 | 0.70282369 |
76 | MAP2K6 | 0.69956891 |
77 | MUSK | 0.69713196 |
78 | MAP3K4 | 0.69561263 |
79 | STK16 | 0.68063037 |
80 | CDK15 | 0.66989003 |
81 | TNK2 | 0.66876701 |
82 | TYRO3 | 0.65155290 |
83 | * CAMK2A | 0.64181655 |
84 | LMTK2 | 0.63654923 |
85 | MAP2K2 | 0.63649624 |
86 | RPS6KA3 | 0.63005443 |
87 | CDK18 | 0.60733459 |
88 | CDK11A | 0.59521819 |
89 | GSK3A | 0.58872678 |
90 | SGK2 | 0.58599730 |
91 | BMPR1B | 0.57963716 |
92 | MAP3K13 | 0.57751074 |
93 | DAPK3 | 0.57375916 |
94 | ABL2 | 0.56764567 |
95 | PRKCH | 0.56348770 |
96 | PRKCE | 0.56191539 |
97 | CASK | 0.55098261 |
98 | SIK1 | 0.53901831 |
99 | IRAK2 | 0.53353288 |
100 | MST4 | 0.52867168 |
101 | CCNB1 | 0.51356233 |
102 | SIK2 | 0.48845510 |
103 | MAP2K4 | 0.48564911 |
104 | BRAF | 0.47994249 |
105 | WNK3 | 0.47044768 |
106 | MAP3K2 | 0.47001424 |
107 | RIPK4 | 0.46891255 |
108 | CSNK1A1 | 0.45932904 |
109 | PRKD3 | 0.45924616 |
110 | CAMK4 | 0.45642851 |
111 | PRKCA | 0.45594781 |
112 | SCYL2 | 0.45207088 |
113 | PDK1 | 0.44439557 |
114 | PRKCZ | 0.44220514 |
115 | BMPR2 | 0.44218791 |
116 | FYN | 0.43779160 |
117 | PRKG1 | 0.43447653 |
118 | SGK3 | 0.38545333 |
119 | STK11 | 0.38169799 |
120 | PIK3CG | 0.38063972 |
121 | BLK | 0.37762570 |
122 | HIPK2 | 0.37724829 |
123 | NTRK2 | 0.37324025 |
124 | CSNK1D | 0.35425997 |
125 | PRKACA | 0.34719790 |
126 | TRPM7 | 0.34537004 |
127 | MAP2K7 | 0.34430385 |
128 | ROCK1 | 0.33179885 |
129 | TAOK3 | 0.32464782 |
130 | RPS6KA5 | 0.31326967 |
131 | MOS | 0.31320576 |
132 | RAF1 | 0.31141888 |
133 | ITK | 0.29124873 |
134 | ADRBK2 | 0.28223879 |
135 | PRKG2 | 0.28209126 |
136 | MAP3K1 | 0.26203711 |
137 | PRKCG | 0.25806150 |
138 | MAPK12 | 0.25302457 |
139 | MAPK7 | 0.24732863 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.48626985 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.65532957 |
3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.33511861 |
4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.27612643 |
5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.11857196 |
6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.95013855 |
7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.85503274 |
8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.82329018 |
9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.78493488 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.69839516 |
11 | Insulin secretion_Homo sapiens_hsa04911 | 2.53976613 |
12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.39542886 |
13 | Long-term potentiation_Homo sapiens_hsa04720 | 2.38813920 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.38540430 |
15 | Circadian entrainment_Homo sapiens_hsa04713 | 2.36533838 |
16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.32477229 |
17 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.21597302 |
18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20272124 |
19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.18042015 |
20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.17061257 |
21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.09104227 |
22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.03502924 |
23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.93997416 |
24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.92877797 |
25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91365690 |
26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.85269487 |
27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84970871 |
28 | Peroxisome_Homo sapiens_hsa04146 | 1.82397831 |
29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.78684576 |
30 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.76213759 |
31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.72413375 |
32 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.68675147 |
33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.62919210 |
34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.55133657 |
35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.52184588 |
36 | Salivary secretion_Homo sapiens_hsa04970 | 1.51339526 |
37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.50870174 |
38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.50517438 |
39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.47478727 |
40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.47314118 |
41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.47264338 |
42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.44039294 |
43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.39384067 |
44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31555812 |
45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.31032133 |
46 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.30717252 |
47 | Renin secretion_Homo sapiens_hsa04924 | 1.26588748 |
48 | Protein export_Homo sapiens_hsa03060 | 1.24212067 |
49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.23430074 |
50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22748044 |
51 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.22474711 |
52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19384340 |
53 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19220850 |
54 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.17616198 |
55 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.15729363 |
56 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15707410 |
57 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.12732650 |
58 | Bile secretion_Homo sapiens_hsa04976 | 1.10297043 |
59 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.09863332 |
60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.09546145 |
61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.04252060 |
62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03151360 |
63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01434355 |
64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95868587 |
65 | Taste transduction_Homo sapiens_hsa04742 | 0.95062512 |
66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.93405944 |
67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92879130 |
68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89930860 |
69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89057770 |
70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.87142681 |
71 | Parkinsons disease_Homo sapiens_hsa05012 | 0.85010406 |
72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83926127 |
73 | Olfactory transduction_Homo sapiens_hsa04740 | 0.82091691 |
74 | ABC transporters_Homo sapiens_hsa02010 | 0.81503446 |
75 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80367453 |
76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.75526053 |
77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75029948 |
78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74415747 |
79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73760441 |
80 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70513397 |
81 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.70349416 |
82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69727572 |
83 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.69652174 |
84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69499793 |
85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68926412 |
86 | Phototransduction_Homo sapiens_hsa04744 | 0.68227759 |
87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67906405 |
88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.67768667 |
89 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67131806 |
90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67121059 |
91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66819595 |
92 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.66219852 |
93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66156298 |
94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64645774 |
95 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.64556370 |
96 | GABAergic synapse_Homo sapiens_hsa04727 | 0.63942072 |
97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62892344 |
98 | Mineral absorption_Homo sapiens_hsa04978 | 0.62353600 |
99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.59611650 |
100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57454236 |
101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55686741 |
102 | Gap junction_Homo sapiens_hsa04540 | 0.55553630 |
103 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.53897146 |
104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53883078 |
105 | Melanogenesis_Homo sapiens_hsa04916 | 0.53765549 |
106 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53686829 |
107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51506191 |
108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49994342 |
109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49812922 |
110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48718346 |
111 | * Folate biosynthesis_Homo sapiens_hsa00790 | 0.47910567 |
112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44711728 |
113 | Prion diseases_Homo sapiens_hsa05020 | 0.42589136 |
114 | Glioma_Homo sapiens_hsa05214 | 0.42028190 |
115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41557546 |
116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41318101 |
117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39792982 |
118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33950524 |
119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33022858 |
120 | Cocaine addiction_Homo sapiens_hsa05030 | 0.32351850 |
121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31978013 |
122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31772009 |
123 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.31545269 |
124 | Lysosome_Homo sapiens_hsa04142 | 0.30077264 |
125 | Endocytosis_Homo sapiens_hsa04144 | 0.29879220 |
126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29708620 |
127 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.28151858 |
128 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.25489510 |
129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.25223126 |
130 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25182522 |
131 | Axon guidance_Homo sapiens_hsa04360 | 0.25023641 |
132 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.22724745 |
133 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21565163 |
134 | Huntingtons disease_Homo sapiens_hsa05016 | 0.19977924 |
135 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18139728 |
136 | Morphine addiction_Homo sapiens_hsa05032 | 0.15139001 |
137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14304152 |
138 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.12030147 |
139 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.11650189 |
140 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.11280996 |
141 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.10052230 |
142 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.09418127 |
143 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.09364440 |
144 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.07773388 |
145 | Long-term depression_Homo sapiens_hsa04730 | 0.07130477 |
146 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.06715461 |